Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × pazopanib × Other solid neoplasm × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 14 Expanded_access 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

tazemetostat 1 pazopanib 1 osunprotafib 1 omburtamab I-131 1 molibresib 1 marizomib 1 carotuximab 1 Pemetrexed 1 Cisplatin 1 Capecitabine 1 Bevacizumab 1 Axitinib 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02354612 2021-02-15

Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial

Tracon Pharmaceuticals Inc.

No longer available

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡